Biotech & Life SciencesRobotics & AutomationTravel & HospitalityMobility & TransportationAIHealthcareClimate & Energy
SV Investment is a South Korea-based venture capital firm that focuses on innovative investments in small and medium-sized venture companies across diverse sectors such as IT, healthcare, biotechnology, and cultural entertainment. Their strategy involves acquiring meaningful stakes, often aiming to be the second-largest shareholder, to provide proactive support and foster global competitiveness and scalability for their portfolio companies.
40% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-a (40% of deals). Average disclosed round size is $22.2M (across 9 rounds with reported amounts).
Portfolio
10
Fund Size
$1.2B
Top Stage
Series A
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
10 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| BBreezeBio | Series B | — | Feb 2026 |
 Avelos Therapeutics | Series B | $12.3M | Apr 2024 |
 Aniai | Series A | $12M | Jan 2024 |
 Myrealtrip | Series F | $56.7M | Jan 2024 |
| MMaka Motors | Seed | $37.6M | Jul 2023 |
 Oculii | Series B | $55M | May 2021 |
 Zeto, Inc. | Series A | $7.3M | Mar 2020 |
 Axiom Exergy | Series A | $7.6M | May 2018 |
 EpiBiome | Series A | $6M | Feb 2016 |
| AANA Therapeutics | Seed | $5M | — |
Top Co-Investors
Shinhan Capital2 shared
Shell1 shared
WorldQuant Ventures1 shared
Mirae Asset1 shared
AC Ventures1 shared
Northstar Group1 shared
Peak XV1 shared
Beenext1 shared
M Ventures1 shared
IMM Investment1 shared
Korelya Capital1 shared
Altos Ventures1 shared
Partech1 shared
Smilegate Investment1 shared
DSC Investment1 shared
STIC Investment1 shared
Top Harvest Capital1 shared
Korea Investment Partners1 shared
Woori Venture Partners1 shared
InterVest1 shared
Last updated: 16 April 2026